Premium
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features.
Author(s) -
Ballestri Stefano,
Nascimbeni Fabio,
Romagnoli Dante,
Lonardo Amedeo
Publication year - 2016
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/hepr.12656
Subject(s) - steatohepatitis , medicine , gastroenterology , fatty liver , steatosis , fibrosis , insulin resistance , metabolic syndrome , waist , liver biopsy , diabetes mellitus , biopsy , endocrinology , disease , obesity
Aim The diagnosis of non‐alcoholic steatohepatitis (NASH) is based on the individual histological features: steatosis, lobular inflammation and ballooning. Non‐alcoholic fatty liver disease (NAFLD) activity score (NAS ≥ 5) is used in clinical trials. Fibrosis dictates long‐term NAFLD prognosis. Recently, more‐than‐mild portal inflammation has raised interest as a marker of NAFLD severity. We assessed the independent predictors of: (I) individual histological lesions of NASH; (II) diagnosis of NASH; (III) significant (stage ≥2) and advanced (stage ≥3) fibrosis; and (IV) more‐than‐mild portal inflammation. Methods Data from 118 consecutive biopsy‐proven NAFLD patients observed at our institution were retrospectively analyzed. Results At stepwise multivariate logistic regression analyses, independent predictors were as follows. For the individual histological features of NASH: insulin resistance (IR), assessed with Homeostasis Model Assessment‐IR (HOMA‐IR), serum uric acid (SUA) and serum total cholesterol (TCH) for moderate‐to‐severe steatosis; waist circumference (waist), HOMA‐IR and TCH for lobular inflammation; waist, HOMA‐IR, metabolic syndrome (MS), serum alanine aminotransferase (ALT), SUA and TCH for ballooning. For NASH diagnosis: waist, HOMA‐IR, MS, ALT, SUA and TCH (Brunt et al. 's classification); ALT, SUA and TCH for NAS ≥ 5. For significant and advanced fibrosis, respectively: waist, MS and ALT; age, platelets, HOMA‐IR, diabetes and TCH. For more‐than‐mild portal inflammation: serum aspartate aminotransferase (AST), serum iron, NAS ≥ 5 and significant liver fibrosis. Conclusion HOMA‐IR, SUA, MS, ALT and TCH are independent predictors of NASH and its individual histological lesions, notably including fibrosis. Based on our findings, these factors should be considered major pathogenic drivers of NASH and, by inference, potential targets for treatment.